Investigating how the environment around tumors affects breast cancer after pregnancy

The Tumor Microenvironment and Lymphatic Remodeling in Postpartum Breast Cancer

['FUNDING_R01'] · COLUMBIA UNIVERSITY HEALTH SCIENCES · NIH-10977424

This study is looking at how breast cancer that happens after having a baby might be different and more serious, and it aims to find ways to help young women who face this challenge by understanding what happens in the tumor environment during this time.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorCOLUMBIA UNIVERSITY HEALTH SCIENCES (nih funded)
Locations1 site (NEW YORK, UNITED STATES)
Trial IDNIH-10977424 on ClinicalTrials.gov

What this research studies

This research focuses on understanding postpartum breast cancer (PPBC), which can be more aggressive and deadly compared to other types of breast cancer. The study examines the tumor microenvironment and how factors like lymphatic remodeling and inflammation during the postpartum period may influence tumor growth and metastasis. By analyzing the immune cells and other elements within the tumor environment, the research aims to identify potential strategies to reduce the risk of PPBC and improve outcomes for affected women. The findings could lead to better risk stratification and treatment options tailored for young women diagnosed with breast cancer after pregnancy.

Who could benefit from this research

Good fit: Ideal candidates for this research are women who have recently given birth and are at risk for postpartum breast cancer.

Not a fit: Patients who are not postpartum or those who have not been diagnosed with breast cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide new insights and strategies to reduce the risk of aggressive breast cancer in women after childbirth.

How similar studies have performed: While there is limited research specifically targeting postpartum breast cancer, studies on tumor microenvironments and immune responses have shown promise in other cancer types.

Where this research is happening

NEW YORK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.